Literature DB >> 11121021

tau kinases in the rat heat shock model: possible implications for Alzheimer disease.

A Shanavas1, S C Papasozomenos.   

Abstract

We have previously shown, by using the phosphate-dependent anti-tau antibodies Tau-1 and PHF-1, that heat shock induces rapid dephosphorylation of tau followed by hyperphosphorylation in female rats. In this study, we analyzed in forebrain homogenates from female Sprague-Dawley rats the activities of extracellular signal regulated kinase 1/2 (ERK1/2), c-Jun NH(2)-terminal kinase (JNK), glycogen synthase kinase-3beta (GSK-3beta), cyclin-dependent kinase 5 (Cdk5), cAMP-dependent protein kinase A (PKA), and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) at 0 (n = 5), 3 (n = 4), 6 (n = 5), and 12 (n = 5) h after heat shock and in non-heat-shocked controls (n = 5). Immunoprecipitation kinase assays at 0 h showed suppression of the activities of all kinases except of GSK-3beta, which showed increased activity. At 3-6 h, the activities of ERK1/2, JNK, Cdk5, and GSK-3beta toward selective substrates were increased; however, only JNK, Cdk5, and GSK-3beta but not ERK1/2 were overactivated toward purified bovine tau. At 3-6 h, kinase assays specific for PKA and CaMKII showed no increased activity toward either tau or selective substrates. All of eight anti-tau antibodies tested showed dephosphorylation at 0 h and hyperphosphorylation at 3-6 h, except for 12E8, which showed hyperphosphorylation also at 0 h. Immunoblot analysis using activity-dependent antibodies against ERK1/2, JNK, and GSK-3beta confirmed the above data. Increased activation and inhibition of kinases after heat shock were statistically significant in comparison with controls. Because tau is hyperphosphorylated in Alzheimer disease these findings suggest that JNK, GSK-3beta, and Cdk5 may play a role in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121021      PMCID: PMC18884          DOI: 10.1073/pnas.97.26.14139

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  64 in total

Review 1.  Tau protein pathology in neurodegenerative diseases.

Authors:  M G Spillantini; M Goedert
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

2.  Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein.

Authors:  A Probst; J Götz; K H Wiederhold; M Tolnay; C Mistl; A L Jaton; M Hong; T Ishihara; V M Lee; J Q Trojanowski; R Jakes; R A Crowther; M G Spillantini; K Bürki; M Goedert
Journal:  Acta Neuropathol       Date:  2000-05       Impact factor: 17.088

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal.

Authors:  M Hetman; J E Cavanaugh; D Kimelman; Z Xia
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

5.  Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2.

Authors:  R L Neve; P Harris; K S Kosik; D M Kurnit; T A Donlon
Journal:  Brain Res       Date:  1986-12       Impact factor: 3.252

6.  Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.

Authors:  H K Paudel; J Lew; Z Ali; J H Wang
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

7.  Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356.

Authors:  J M Litersky; G V Johnson; R Jakes; M Goedert; M Lee; P Seubert
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

8.  Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.

Authors:  S C Papasozomenos
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

9.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

10.  The promoter of Alzheimer's disease amyloid A4 precursor gene.

Authors:  J M Salbaum; A Weidemann; H G Lemaire; C L Masters; K Beyreuther
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  4 in total

1.  Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease.

Authors:  Sozos Ch Papasozomenos; Alikunju Shanavas
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  Nuclear tau, a key player in neuronal DNA protection.

Authors:  Audrey Sultan; Fabrice Nesslany; Marie Violet; Séverine Bégard; Anne Loyens; Smail Talahari; Zeyni Mansuroglu; Daniel Marzin; Nicolas Sergeant; Sandrine Humez; Morvane Colin; Eliette Bonnefoy; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

Review 3.  Cdk5 as a drug target for the treatment of Alzheimer's disease.

Authors:  Lit-Fui Lau; Patricia A Seymour; Mark A Sanner; Joel B Schachter
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

Review 4.  Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation.

Authors:  Nahid Ahmadian; Sajjad Hejazi; Javad Mahmoudi; Mahnaz Talebi
Journal:  Basic Clin Neurosci       Date:  2018-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.